LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 73 filers reported holding LEGEND BIOTECH CORP in Q1 2021. The put-call ratio across all filers is 3.21 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $448,024 | -18.9% | 6,670 | -16.6% | 0.09% | -5.4% |
| Q2 2023 | $552,240 | +14.5% | 8,000 | -20.0% | 0.09% | -1.1% |
| Q1 2023 | $482,200 | +7.3% | 10,000 | +11.1% | 0.09% | +6.9% |
| Q4 2022 | $449,280 | +22.4% | 9,000 | 0.0% | 0.09% | +20.8% |
| Q3 2022 | $367,000 | -33.3% | 9,000 | -10.0% | 0.07% | -35.1% |
| Q2 2022 | $550,000 | +26.1% | 10,000 | -16.7% | 0.11% | +44.2% |
| Q1 2022 | $436,000 | +33.7% | 12,000 | +71.4% | 0.08% | +57.1% |
| Q4 2021 | $326,000 | -12.8% | 7,000 | -5.4% | 0.05% | +58.1% |
| Q3 2021 | $374,000 | +23.0% | 7,400 | 0.0% | 0.03% | +24.0% |
| Q2 2021 | $304,000 | +1.7% | 7,400 | -28.2% | 0.02% | +8.7% |
| Q1 2021 | $299,000 | – | 10,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $56,230,872 | 17.46% |
| Paradigm Biocapital Advisors LP | 1,805,717 | $124,648,645 | 9.63% |
| HHLR ADVISORS, LTD. | 6,436,533 | $444,313,873 | 9.46% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,692 | $77,568,459 | 9.09% |
| RA Capital Management | 6,264,707 | $432,452,724 | 8.16% |
| Tri Locum Partners LP | 116,768 | $8,060,495 | 3.00% |
| Nicholas Investment Partners, LP | 593,167 | $40,946,318 | 2.80% |
| E Fund Management (Hong Kong) Co., Ltd. | 51,679 | $3,567 | 2.66% |
| Avidity Partners Management LP | 798,900 | $55,148,067 | 1.93% |
| Boxer Capital, LLC | 600,000 | $41,418 | 1.92% |